MyOme news and updates
Myome received financing of $23M in series B financing round on Jun 21st 22'.
The oversubscribed series B financing led by Healthcare Venture Partners, added SoftBank Corp. and Natera to existing investors– Sequoia Capital, Foresite Capital, Founders Fund, among others MENLO PARK, Calif., June 21, 2022 /PRNewswire/ -- MyOme, a clinical whole genome platform analysis company, today announced that the company has raised $23 million in an oversubscribed series B financing round led by Healthcare Venture Partners, bringing the total raised to over $36M.
Jan 1, 2022 | prnewswire.comMyome launches data on cross-ancestry integrated risk score for breast cancer risk assessment
MyOme, a clinical whole genome platform analysis company, today announced new data on its cross-ancestry integrated risk score (caIRS) for breast cancer risk assessment that will be presented at the 2022 American Society of Human Genetics (ASHG) Annual Meeting in Los Angeles.
Oct 26, 2022 | topionetworks.com